by EmpathiCSubstanceS | Dec 26, 2018 | Anxiety
Researchers at Johns Hopkins University have suggested that psilocybin, which is found in hallucinogenic mushrooms, be reclassified from a Schedule I drug, with no known medical benefit, to a Schedule IV drug, which is akin to prescription sleeping pills....
by EmpathiCSubstanceS | Dec 26, 2018 | Anxiety
Researchers report LSD triggers a reduction in functional connection between areas of the brain that govern cognitive processes, while increasing connectivity in brain networks associated with sensory functions. Psychedelic drugs such as LSD have a profound impact on...
by EmpathiCSubstanceS | Dec 26, 2018 | Depression
Preliminary study suggests that ‘microdoses’ of psychedelics may enhance a person’s creative problem solving abilities The use of minute doses of magic mushrooms and truffles containing psychedelic substances could induce a state of unconstrained...
by EmpathiCSubstanceS | Nov 20, 2018 | Anxiety
Commonly referred to as ecstasy or molly, MDMA is anecdotally known to make people more open to empathetically interacting with those around them. However, a new study from King’s College London has revealed that while the drug may increase cooperative behavior,...
by EmpathiCSubstanceS | Nov 2, 2018 | Anxiety
Newly published results from a Phase 2 clinical trial into the efficacy of MDMA-assisted psychotherapy in treating post-traumatic stress disorder (PTSD) have revealed striking success, with 76 percent of subjects not meeting the standard clinical criteria for PTSD 12...
